U.S. Exosomes Market Size, Share & Trends Analysis Report By Product (Kits & Reagents, Services), By Application (Cancer, CVD), By Workflow (Isolation Methods, Downstream Analysis), By End-use, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                      1.1. Market Segmentation & Scope
                      1.2. Segment Definitions
                          1.2.1. Product
                          1.2.2. Application
                          1.2.3. Workflow
                          1.2.4. End-use
                          1.2.5. Estimates and forecasts timeline
                      1.3. Research Methodology
                      1.4. Information Procurement
                          1.4.1. Purchased database
                          1.4.2. GVR’s internal database
                          1.4.3. Secondary sources
                          1.4.4. Primary research
                          1.4.5. Details of primary research
                              1.4.5.1. Data for primary interviews in the U.S.
                      1.5. Information or Data Analysis
                          1.5.1. Data analysis models
                      1.6. Market Formulation & Validation
                      1.7. Model Details
                          1.7.1. Commodity flow analysis (Model 1)
                          1.7.2. Approach 1: Commodity flow approach
                          1.7.3. Volume price analysis (Model 2)
                          1.7.4. Approach 2: Volume price analysis
                      1.8. List of Secondary Sources
                      1.9. List of Primary Sources
                      1.10. Objectives
Chapter 2. Executive Summary
                      2.1. Market Outlook
                      2.2. Segment Outlook
                          2.2.1. Product
                          2.2.2. Application
                          2.2.3. Workflow
                          2.2.4. End-use
                      2.3. Competitive Insights
Chapter 3. U.S. Exosomes Market Variables, Trends, & Scope
                      3.1. Market Lineage Outlook
                          3.1.1. Parent market outlook
                          3.1.2. Related/ancillary market outlook
                      3.2. Market Dynamics
                      3.3. Market Driver Analysis
                      3.4. Market Restraint Analysis
                      3.5. Industry Analysis - Porter’s Five Forces
                          3.5.1. Supplier power
                          3.5.2. Buyer power
                          3.5.3. Substitution threat
                          3.5.4. Threat of new entrant
                          3.5.5. Competitive rivalry
                      3.6. PESTEL Analysis
                          3.6.1. Political landscape
                          3.6.2. Technological landscape
                          3.6.3. Economic Landscape
Chapter 4. U.S. Exosomes Market Product Estimates & Trend Analysis
                      4.1. U.S. Exosomes Product Model Dashboard
                      4.2. U.S. Exosomes Product Movement Analysis
                      4.3. Kits & Reagents
                          4.3.1. Kits & Reagents Market, 2018 - 2030 (USD Million)
                      4.4. Instruments
                          4.4.1. Instruments Market, 2018 - 2030 (USD Million)
                      4.5. Services
                      4.6. Services Market, 2018 - 2030 (USD Million)
Chapter 5. U.S. Exosomes Market Application & Trend Analysis
                      5.1. U.S. Exosomes market Application Model Dashboard
                     5.2. U.S. Exosomes Market Application Movement Analysis
                      5.3. Cancer
                          5.3.1. Cancer Market, 2018 - 2030 (USD Million)
                      5.4. Neurodegenerative Diseases
                          5.4.1. Neurodegenerative Diseases Market, 2018 - 2030 (USD Million)
                      5.5. Cardiovascular Diseases
                          5.5.1. Cardiovascular Diseases Market, 2018 - 2030 (USD Million)
                      5.6. Infectious Diseases
                          5.6.1. Infectious Diseases Market, 2018 - 2030 (USD Million)
                      5.7. Others
                          5.7.1. Other Applications Market, 2018 - 2030 (USD Million)
Chapter 6. U.S. Exosomes Market Workflow Estimates & Trend Analysis
                      6.1. U.S. Exosomes Market Workflow Model Dashboard
                      6.2. U.S. Exosomes Market Workflow Movement Analysis
                      6.3. Isolation Methods
                      6.4. Isolation Methods Market, 2018 - 2030 (USD Million)
                          6.4.1. Ultracentrifugation
                              6.4.1.1. Ultracentrifugation Market, 2018 - 2030 (USD Million)
                          6.4.2. Immunocapture On Beads
                              6.4.2.1. Immunocapture On Beads Market, 2018 - 2030 (USD Million)
                          6.4.3. Precipitation
                              6.4.3.1. Precipitation Market, 2018 - 2030 (USD Million)
                          6.4.4. Filtration
                              6.4.4.1. Filtration Market, 2018 - 2030 (USD Million)
                          6.4.5. Others
                              6.4.5.1. Other Isolation Methods Market, 2018 - 2030 (USD Million)
                      6.5. Downstream Analysis
                          6.5.1. Downstream Analysis Market, 2018 - 2030 (USD Million)
                          6.5.2. Cell Surface Marker Analysis Using Flow Cytometry
                              6.5.2.1. Cell Surface Marker Analysis Using Flow Cytometry Market, 2018 - 2030 (USD Million)
                          6.5.3. Protein Analysis Using Blotting & Elisa
                              6.5.3.1. Protein Analysis Using Blotting & Elisa Market, 2018 - 2030 (USD Million)
                          6.5.4. RNA Analysis With NGS & PCR
                              6.5.4.1. RNA Analysis With NGS & PCR Market, 2018 - 2030 (USD Million)
                          6.5.5. Proteomic Analysis Using Mass Spectrometry
                              6.5.5.1. Proteomic Analysis Using Mass Spectrometry Market, 2018 - 2030 (USD Million)
                          6.5.6. Others
                              6.5.6.1. Other Downstream Analysis Market, 2018 - 2030 (USD Million)
Chapter 7. U.S. Exosomes Market End-use Estimates & Trend Analysis
                      7.1. U.S. Exosomes Market End-use Model Dashboard
                      7.2. U.S. Exosomes Market End-use Movement Analysis
                      7.3. Pharmaceutical & Biotechnology Companies
                          7.3.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
                      7.4. Hospitals & Diagnostics Centers
                          7.4.1. Hospitals & Diagnostics Centers Market, 2018 - 2030 (USD Million)
                      7.5. Academic & Research Institutes
                          7.5.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
                      8.1. Recent Developments & Impact Analysis, By Key Market Participants
                      8.2. Company/Competition Categorization
                          8.2.1. Vendor Landscape
                          8.2.2. List of key distributors and channel partners
                          8.2.3. Key customers
                          8.2.4. Key company market share analysis, 2023
                          8.2.5. Danaher
                              8.2.5.1. Company overview
                              8.2.5.2. Financial performance
                              8.2.5.3. Product benchmarking
                              8.2.5.4. Strategic initiatives
                          8.2.6. Thermo Fisher Scientific, Inc.
                              8.2.6.1. Company overview
                              8.2.6.2. Financial performance
                              8.2.6.3. Product benchmarking
                              8.2.6.4. Strategic initiatives
                          8.2.7. Hologic Inc.
                              8.2.7.1. Company overview
                              8.2.7.2. Financial performance
                              8.2.7.3. Product benchmarking
                              8.2.7.4. Strategic initiatives
                          8.2.8. Bio-Techne
                              8.2.8.1. Company overview
                              8.2.8.2. Financial performance
                              8.2.8.3. Product benchmarking
                              8.2.8.4. Strategic initiatives
                          8.2.9. RoosterBio, Inc
                              8.2.9.1. Company overview
                              8.2.9.2. Financial performance
                              8.2.9.3. Product benchmarking
                              8.2.9.4. Strategic Initiatives
                          8.2.10 Aragen Bioscience
                              8.2.10.1. Company overview
                              8.2.10.2. Financial performance
                              8.2.10.3. Product benchmarking
                              8.2.10.4. Strategic initiatives
                          8.2.11. Capricor Therapeutics
                              8.2.11.1. Company Overview
                              8.2.11.2. Financial performance
                              8.2.11.3. Product benchmarking
                              8.2.11.4. Strategic initiatives
                          8.2.12. Coya Therapeutics
                              8.2.12.1. Company Overview
                              8.2.12.2. Financial performance
                              8.2.12.3. Product benchmarking
                              8.2.12.4. Strategic initiatives
                          8.2.13. Aegle Therapeutics Corporation
                              8.2.13.1. Company Overview
                              8.2.13.2. Financial performance
                              8.2.13.3. Product benchmarking
                              8.2.13.4. Strategic initiatives
                          8.2.14. Aethlon Medical
                              8.2.14.1. Company Overview
                              8.2.14.2. Financial performance
                              8.2.14.3. Product benchmarking
                              8.2.14.4. Strategic initiatives

List of Tables

Table 1. List of abbreviations
Table 2. U.S. Exosomes Market, By Product, 2018 - 2030 (USD Billion)
Table 3. U.S. Exosomes Market, By Application, 2018 - 2030 (USD Billion)
Table 4. U.S. Exosomes Market, By Workflow, 2018 - 2030 (USD Billion)
Table 5. U.S. Exosomes Market, By End-use, 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 Market Research Process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 U.S. Exosomes Market Segmentation
Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 11 Penetration & Growth Prospect Mapping
Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 13 Porter’s Five Forces Analysis
Fig. 14 U.S. Exosomes Market: Product outlook and key takeaways
Fig. 15 U.S. Exosomes Market: Product movement analysis & market share 2023 & 2030
Fig. 16 Kits & reagents market, 2018 - 2030 (USD Million)
Fig. 17 Instruments market, 2018 - 2030 (USD Million)
Fig. 18 Services market, 2018 - 2030 (USD Million)
Fig. 19 U.S. Exosomes Market: Application outlook and key takeaways
Fig. 20 U.S. Exosomes Market: Application movement analysis & market share
Fig. 21 Isolation methods market, 2018 - 2030 (USD Million)
Fig. 22 Ultracentrifugation market, 2018 - 2030 (USD Million)
Fig. 23 Immunocapture on beads market, 2018 - 2030 (USD Million)
Fig. 24 Precipitation market, 2018 - 2030 (USD Million)
Fig. 25 Filtration market, 2018 - 2030 (USD Million)
Fig. 26 Other isolation methods market, 2018 - 2030 (USD Million)
Fig. 27 Downstream analysis market, 2018 - 2030 (USD Million)
Fig. 28 Cell surface marker analysis using flow cytometry market, 2018 - 2030 (USD Million)
Fig. 29 Protein analysis using blotting & ELISA market, 2018 - 2030 (USD Million)
Fig. 30 RNA analysis with NGS & PCR market, 2018 - 2030 (USD Million)
Fig. 31 Proteomic analysis using mass spectroscopy market, 2018 - 2030 (USD Million)
Fig. 32 Other downstream analysis market, 2018 - 2030 (USD Million)
Fig. 33 U.S. Exosomes Market: Application outlook and key takeaways
Fig. 34 U.S. Exosomes Market: Application movement analysis & market share
Fig. 35 Cancer market, 2018 - 2030 (USD Million)
Fig. 36 Neurodegenerative diseases market, 2018 - 2030 (USD Million)
Fig. 37 Cardiovascular diseases market, 2018 - 2030 (USD Million)
Fig. 38 Infectious diseases market, 2018 - 2030 (USD Million)
Fig. 39 Other applications market, 2018 - 2030 (USD Million)
Fig. 40 U.S. Exosomes Market: End-use outlook and key takeaways
Fig. 41 U.S. Exosomes Market: End-use movement analysis & market share
Fig. 42 Pharmaceutical & biotechnology companies market, 2018 - 2030 (USD Million)
Fig. 43 Hospitals & diagnostics centers market estimates and forecast, 2018 - 2030
Fig. 44 Academic and research institutes market estimates and forecast, 2018 - 2030
Fig. 45 Others market estimates and forecast, 2018 - 2030